Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2026-01-06 @ 5:10 AM
Study NCT ID:
NCT06023758
Status:
RECRUITING
Last Update Posted:
2024-05-10
First Post:
2023-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
Sponsor:
Peking University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
KHER2-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None